CD Bioparticles Launches Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research
CD Bioparticles announces the launch of its new Tumor Organoid & CAF Co-culture services for researchers. New York, United States, September 17, 2025 — CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery… Read More »CD Bioparticles Launches Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research





